Global Famotidine Injection Market Overview:
Famotidine injection is used in people who are hospitalized to treat certain conditions in which the stomach produces too much acid, or to treat ulcers (wounds in the stomach or intestinal mucosa) that are unsuccessful with other drugs were treated. Famotidine injection is also used for a short time in people who cannot take oral medication. The injection of famotidine belongs to a class of drugs called H2 blockers. It basically works hereby reducing the amount of acid that is produced in the stomach. The famotidine injection is supplied as a solution (liquid) that is mixed with another liquid and injected intravenously (into a vein) for 2 to 30 minutes. It is also available as a pre-mixed product that can be injected intravenously over a period of 15 to 30 minutes. It is usually given every 12 hours.
- Increasing Adoption Due To Wide Range of Medical Applications of Famotidine
- Increased Prevalence of Diseases such as Stomach Ulcers and GERD
- Increased number of Hospitals and Clinics
- Development of New Diagnostic Centres and Hospitals
- Growing Focus on Preventive Healthcare
- The Emergence of Developing Economies Such As India and China
- The Growing Technological Advancements in the Famotidine
- Increasing Awareness Regarding the Treatment
- Growing Number of Online Pharmacies
- Lack of Proper Diagnosis
- Less Awareness among the People in Developing Countries
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Medline Industries (United States), Allegiance Health (United States), Ciron Group (India), CVS Health (United States), Mylan N.V. (United States) and McKesson Pharma (United States). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Famotidine Injection market by 2025. Considering Market by Components, the sub-segment i.e. L-aspartic Acid will boost the Famotidine Injection market. Considering Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Famotidine Injection market. Considering Market by Age Group, the sub-segment i.e. Pediatric Patients < 1 Year of Age will boost the Famotidine Injection market. Considering Market by Side Effects, the sub-segment i.e. Headache will boost the Famotidine Injection market.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Famotidine Injection market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Famotidine Injection market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Providers of Famotidine Injection, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.